Background: Changes in plasma and intracellular calcium levels have been suggested in the pathogenesis of pre-eclampsia, however, membrane calcium content has not been studied so far. We compared intracellular and membrane calcium concentrations in erythrocytes of women with pre-eclampsia, healthy pregnant woman and controls to determine a possible alteration of membrane calcium in pre-eclampsia. Subjects and methods: Eighteen untreated, healthy pregnant woman and 16 pregnant nulliparous women with manifest pre-eclampsia were included, 25 healthy, age-matched woman served as controls. Atomic absorption spectroscopy was used for measurement of intracellular and membrane calcium content in erythrocytes and plasmalemmal preparations. Results: Plasma Ca ؉؉ concentrations were significantly
Introduction
Pre-eclampsia defined as hypertension and proteinuria beginning in the second half of gestation affects about 5% of all pregnant woman and is a leading cause of maternal and foetal death throughout the world. 1, 2 Numerous clinical trials in the last decade evaluated the use of various methods to reduce the incidence or severity of pre-eclampsia, however, results are disappointing. [3] [4] [5] Prevention of the disease requires more detailed knowledge of its pathogenesis as well as the availability of methods for prediction of those at risk for the disorder. In the last couple of years growing attention has been directed towards the possible role of calcium in the development of pregnancy-induced hypertension and pre-eclampsia. 6 Increased intracellular calcium concentrations have been reported in erythrocytes and platelets in pre-eclampsia. [7] [8] [9] However, results concerning calcium metabolism in pregnancy are equivocal. 10 The use of calcium supplementation for prevention and treatment of pre-eclampsia is also controversely discussed. Oral calcium supplementation and thus increase of plasma calcium alone seem not to reduce the incidence of the disease. 3, 4 The calcium status of cell membranes of red blood cells in pre-eclamptic women has not been studied so far. However, membrane calcium content may be of importance since altered transmembrane flux of calcium has been suggested in pre-eclampsia.
11,12
Therefore we measured plasma, intracellular and erythrocyte membrane calcium concentrations in pre-eclampsia and normal pregnancy and compared results to normal control subjects. The hypothesis of our study was that intracellular and membrane calcium status may be different from plasma calcium levels and that membrane calcium transport is altered in pre-eclampsia.
Patients and methods

Subjects
Our study conforms with the principles outlined in the declaration of Helsinki and was performed in accordance with protocols approved by the local ethics committee at the University of Mü nster. Each subject gave informed consent to participate. Sixteen patients with manifest pre-eclampsia and 18 healthy, untreated woman with uncomplicated pregnancy matched for age and duration of pregnancy were included in this study. In both groups only nulliparous women were included. The diagnosis of pre-eclampsia was made according to the guidelines of the British Hypertension Society and the International Society of Hypertension 2,13 by a rise in diastolic blood pressure of Ͼ15 mm Hg or in systolic blood pressure Ͼ25 mm Hg or a blood pressure of Ͼ140 mm Hg systolic or Ͼ90 mm Hg diastolic on at least two independent occasions 4 h apart or a diastolic pressure Ͼ110 mm Hg on one occasion and proteinuria (Ͼ300 mg/24 h is the criterion for diagnosis).
Twenty-five normotensive, healthy, untreated, non-pregnant and age-matched women served as controls. To serve as normotensive controls, subjects had to have a diastolic blood pressure below 90 mm Hg on three separate occasions in the absence of antihypertensive medication. Standard laboratory assays were used to determine concentrations of serum creatinine, potassium and natrium. Clinical data of patients and control subjects are shown in Table 1 .
Blood pressure measurements
Left brachial artery blood pressure was measured using an automatic sphygmomanometer (Critikon Dinamap model 1846 SX, Tampa, FL, USA).
Calcium measurements
All calcium measurements in plasma, erythrocytes and plasmalemmal membrane preparations were performed using an atomic absorption spectroscope (Thermo Jarrell Ash Video, Thermo Jarrell, Andover, USA). Twenty millilitres of heparinized blood was drawn and centrifugated at 2500 g and plasma for measurements was removed. Calibration curves were established using solutions with known Ca 
33.8 ± 2.4 35.2 ± 2.1 0 *Indicates P Ͻ 0.01 for differences between pre-eclamptic patients and controls/healthy pregnant women.
The intra-assay variability was 4.6% in 10 consecutive measurements and the inter-assay variability was between 4 and 7%. Erythrocyte and plasmalemmal membrane preparations were performed as described elsewhere.
14 Briefly, erythrocytes were washed three times by sedimenting in a swingingbucket rotor (2300 g for 10 min) and the pellet resuspended in 5 mmol/l phosphate buffered saline (150 nmol/l sodium chloride and 5 mmol/l sodium phosphate, pH 8.0). The buffy coat was carefully aspirated each time from the surface of the pellet. Hemolysis was initiated by rapidly and thoroughly mixing of 1 ml packed cells with 40 ml of 5 mmol/l sodium phosphate at pH 8.0.
The membrane ghosts were pelleted by centrifugation at 22000 g for 10 min in an angle-head rotor. The supernatant was removed with a top aspirator. The tube was tipped and rotated on its axis so that the loose ghosts slid from a small hard button, rich in contaminating proteases, which could then be aspirated. After two more identical cycles the ghost membranes were creamy white and morphologically intact based on previous investigations and on optical control. 14 
The Ca
++ contents were then determined by atomic spectroscopy and referred to membrane protein content. The measurements of protein content were performed using Coomassie Blue (Serva, Deisenhofen, Germany) according to Bradford's method. 15 By this method the confounding influence of differences in hematocrit or amounts of erythrocyte proteins was minimised.
Statistics
Data are expressed as mean ± standard error of the mean (s.e.m.). Linear regression analysis was performed to assess the relationship between calcium concentrations and blood pressure. Comparison between groups was performed by analysis of variance using a post-hoc test (Fisher PLSD). Nominal variables were compared by 2 test. Statistical significance was assumed at two-tailed P-values Ͻ0.05. Table 2 shows plasma, intracellular and membrane calcium concentrations in patients with pre-eclampsia, healthy pregnant women and control subjects. Plasma Ca ++ concentrations were significantly lower in women with pre-eclampsia compared to healthy pregnant and control subjects (P Ͻ 0.01). No difference was found between plasma Ca ++ concentrations in healthy pregnancy and non-pregnant control subjects.
Results
No significant difference was found in intracellular Ca ++ concentrations in patients with pre-eclampsia, normal pregnancy or control subjects (Table 2 ). In contrast, membrane Ca ++ content was found to be significantly higher in patients with pre-eclampsia compared to controls (P Ͻ 0.01) or compared to healthy, pregnant women (P Ͻ 0.01) (Figure 1 ). Membrane Ca ++ content was not found to be changed in women with uncomplicated pregnancy compared to non-pregnant controls.
In both normotensive control subjects and patients with pre-eclampsia there was no significant correlation between blood pressure and plasma Ca 
Discussion
Several abnormalities in calcium metabolism have been reported in pre-eclampsia. 16 However, reports regarding changes in serum total calcium concentration are equivocal, a number of studies found decreased serum levels in normal pregnancy, others reported no difference in serum calcium levels of pre-eclamptic women and healthy pregnant women or non-pregnant controls. [6] [7] [8] [9] [10] The controversial reports may be in part due to small numbers of Journal of Human Hypertension patients. A possible beneficial effect of calcium supplementation in pregnancy is also discussed controversially. 3, 4 The discrepancy in published reports indicates that serum calcium levels may not be an adequate parameter of calcium metabolism in pre-eclampsia, intracellular and membrane calcium content being more relevant.
We report a significantly increased calcium content of erythrocyte membranes associated with decreased plasma calcium levels in patients with manifest pre-eclampsia compared to healthy pregnant women and non-pregnant control subjects.
The finding of significant decreased plasma calcium levels in pre-eclampsia in our study confirms results of other studies who found low plasma levels of free calcium in pre-eclamptic women.
11,17 A limitation of plasma measurements in our and other studies is a possible influence of differences in binding of calcium to plasma proteins such as albumin. We did not measure free calcium concentrations, however, since patients and controls did not differ significantly in plasma albumin concentrations, this should not have had a major confounding influence on the results. Additionally, Mochizuki et al 11 found increased free calcium levels in platelets and suggested alterations in calcium flux and membrane mechanisms in pre-eclampsia explaining the increased vascular reactivity and enhanced pressor responsiveness which is typical for the disease. A decreased level of 1,25-dihydroxyvitamin D or a relative calcium deficiency due to the increased maternal-foetal transfer of calcium has been suggested as a mechanism of the lowered plasma calcium concentrations and the often observed hypocaliuria in pre-eclampsia. 18 However, mechanisms leading to changes in intracellular and membrane calcium content remain unclear. Hojo et al 7 found increased free calcium concentrations in lymphocytes of pre-eclamptic women and a relation to calcium-deprived extracellular medium in vitro and suggested a direct cellular effect of lower plasma calcium.
However, intracellular calcium concentrations in erythrocytes were not significantly different between groups in our study. This discrepancy may be explained by differences in the physiology of the studied blood cells, eg, lymphocytes, platelets and erythrocytes. Additionally, the extracellular milieu and the different plasma calcium concentrations seem to influence the intracellular concentrations by an altered membrane flux. 7 Our study is the first to compare membrane calcium contents with intracellular and plasma concentrations. We found a significantly elevated membrane calcium content despite normal intra-cellular concentrations, suggesting a primary membrane mechanism. Several possible factors may contribute to the increased calcium membrane concentration. Kilby Some limitations have to be considered when interpreting our results. It can not be clarified by the design of our study whether the observed changes in Ca ++ metabolism are the cause or consequence of the disease. Additionally, a different intravascular volume in pregnancy or in pre-eclampsia, different aged red blood cell populations, or influence of stress on intravascular volume may have contributed to the observed differences in Ca ++ contents of erythrocyte membranes. However, since patients did not show major differences at routine laboratory tests and full blood count and were matched for duration of pregnancy it is unlikely that this was a major confounding factor.
We conclude that the calcium content of erythrocytic cell membranes is increased in patients with pre-eclampsia despite low plasma levels. These results suggest a membrane mechanism contributing to the alterations in calcium metabolism in this hypertensive disorder. Further studies are needed to define a possible role of changes in membrane calcium content in the pathogenesis of pre-eclampsia and to clarify whether similar alterations can be observed in vascular smooth muscle cells contributing to the increased contractibility observed in the disorder.
